[Laparoscopic rectal resection technique].
The quality of radical oncological operations for patients with rectal cancer determines the rate of local recurrence and long-term survival. Neoadjuvant chemoradiotherapy for locally advanced tumors, a standardized surgical procedure for rectal tumors less than 12 cm from the anus with total mesorectal excision (TME) and preservation of the autonomous nerve system for sexual and bladder function have significantly improved the oncological results and quality of life of patients. The TME procedure for rectal resection has been performed laparoscopically in Germany for almost 20 years; however, no reliable data are available on the frequency of laparoscopic procedures in rectal cancer patients in Germany. The rate of minimally invasive procedures is estimated to be less than 20 %. A prerequisite for using the laparoscopic approach is implicit adherence to the described standards of open surgery. Available data from prospective randomized trials, systematic reviews and meta-analyses indicate that in the early postoperative phase the generally well-known positive effects of the minimally invasive approach to the benefit of patients can be realized without any long-term negative impact on the oncological results; however, the results of many of these studies are difficult to interpret because it could not be confirmed whether the hospitals and surgeons involved had successfully completed the learning curve. In this article we would like to present our technique, which we have developed over the past 17 years in more than 1000 patients. Based on our experiences the laparoscopic approach can be highly recommended as a suitable alternative to the open procedure.
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Klinikum Augsburg, Stenglinstr.2, 86156, Augsburg, Deutschland. anthuber@klinikum-augsburg.de.
M
M
Anthuber
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Klinikum Augsburg, Stenglinstr.2, 86156, Augsburg, Deutschland.
B
B
Kriening
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Klinikum Augsburg, Stenglinstr.2, 86156, Augsburg, Deutschland.
M
M
Schrempf
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Klinikum Augsburg, Stenglinstr.2, 86156, Augsburg, Deutschland.
B
B
Geißler
Institut für Pathologie, Klinikum Augsburg, Augsburg, Deutschland.
B
B
Märkl
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Klinikum Augsburg, Stenglinstr.2, 86156, Augsburg, Deutschland.
S
S
Rüth
D059186:Chemoradiotherapy, Adjuvant / Q000379:methods / Q000592:standards; D003131:Combined Modality Therapy / Q000379:methods / Q000592:standards; D061887:Conversion to Open Surgery / Q000379:methods / Q000592:standards; D006801:Humans; D010535:Laparoscopy / Q000379:methods* / Q000592:standards; D019060:Minimally Invasive Surgical Procedures / Q000379:methods* / Q000592:standards; D056888:Patient Positioning / Q000379:methods / Q000592:standards; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D011785:Quality Assurance, Health Care / Q000592:standards; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000473:pathology / Q000601:surgery*
Conversion to open surgery; Laparoscopic surgery; Minimally invasive surgery; Rectal cancer; Surgical technique